BEROSEREN drag 29 mg 180 pce

7680697150030 CH-69715 N05C 01.04.1.

No images available

Details

Product number
6971501
CPT
-
Packaging group
180
Unit
Tablette(n)
Composition
valerianae extractum hydroalcoholicum siccum (Valeriana officinalis L. s.l., radix) 29 mg, DER: 3-6:1, Auszugsmittel ethanolum 60% (V/V), passiflorae herbae extractum siccum (Passiflora incarnata L., herba) 13 mg, DER: 4-7:1, Auszugsmittel ethanolum 60% (V/V), crataegi folii cum flore extractum siccum (Crataegus monogyna Jacq. (Lindm.), folium cum flore) 5.4 mg, DER: 4-7:1, Auszugsmittel aqua ad extracta praeparanda, ballotae nigrae herbae extractum aquosum siccum (Ballota nigra L., herba) 4.5 mg, DER: 4-6:1, Auszugsmittel aqua ad extracta praeparanda, maltodextrinum, silica colloidalis anhydrica, magnesii oxidum ponderosum, cellulosum microcristallinum, magnesii stearas, aqua purificata, Überzug: lacca, acaciae gummi, saccharum 153.87 mg, talcum, cera carnauba, aqua purificata, natrii benzoas 6.6 µg corresp. natrium 1 µg, titanii dioxidum, E 172 (flavum), E 172 (nigrum), E 172 (rubrum), pro compresso obducto.

Articles (1)

Beroseren, überzogene Tablette
Tablette
180
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
valerianae extractum hydroalcoholicum siccum
29.0 MG Substance Wirkstoff (Principe actif)
passiflorae herbae extractum siccum
13.0 MG Substance Wirkstoff (Principe actif)
crataegi folii cum flore extractum siccum
5.4 MG Substance Wirkstoff (Principe actif)
ballotae nigrae herbae extractum aquosum siccum
4.5 MG Substance Wirkstoff (Principe actif)
maltodextrinum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii oxidum ponderosum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
aqua purificata
- Substance HNIDK
lacca
- Substance HNIDK
acaciae gummi
- Substance HNIDK
saccharum
153.87 MG Substance HBESI
talcum
- Substance HNIDK
cera carnauba
- Substance HNIDK
aqua purificata
- Substance HNIDK
natrii benzoas
6.6 UG Substance HBESI
natrium
1.0 UG Substance HBESI
titanii dioxidum
- Substance HNIDK
E 172 (flavum)
- Substance HNIDK
E 172 (nigrum)
- Substance HNIDK
E 172 (rubrum)
- Substance HNIDK

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
69715
Drug name
Beroseren, überzogene Tablette
Galenic form
UEBT
ATC Code
N05C
Authorization status
Z
Dispensation category
D
First authorization
04/04/2025
Authorization expiration date
03/04/2030
IT number
01.04.1.
Domain
Human medicine
Field of application
Traditionsgemäss zur Besserung des Befindens bei nervlicher Belastung und zur Förderung des Schlafes

Packaging details

Description (FR)
BEROSEREN drag 29 mg 180 pce
Description (DE)
BEROSEREN Drag 29 mg 180 Stk
Market launch
01/06/2027
Narcotic (BTM)
No

Other packaging sizes

BEROSEREN drag 29 mg 40 pce
40 TABL
GTIN: 7680697150016
View
BEROSEREN drag 29 mg 120 pce
120 TABL
GTIN: 7680697150023
View
Buy us a coffee Explore the data